Patents : |  |
| US Patent No. | Title |
| 7473701 | Substituted indazoles, compositions containing them, method of production and use
|
| 7527925 | Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct
|
| 7528109 | Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
|
| 7528147 | Pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
|
| 7531531 | Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles
|
| 7534608 | Methods of producing pancreatic hormones
|
| 7534792 | Pyrrolotriazine kinase inhibitors
|
| 7534797 | 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors
|
| 7537896 | Androgen-regulated PMEPA1 gene and polypeptides
|
| 7541354 | Bicyclo-pyrazoles
|
| 7541378 | Condensed heterocyclic pyrazole derivatives as kinase inhibitors
|
| 7524835 | Tetrol steroids and esters
|
| 7521211 | IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof
|
| 7517863 | Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide
|
| 7482147 | Ubiquitin protease
|
| 7482354 | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
|
| 7485308 | 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
|
| 7485661 | Heterobicyclic pyrazole derivatives as kinase inhibitors
|
| 7488576 | Methods for diagnosis and treatment of psychiatric disorders
|
| 7504410 | Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
|
| 7510881 | Method and kit for the quantitative and/or qualitative detection of components in a sample
|
| 7511047 | Kinase inhibitors
|
| 7511136 | Aminoindazole derivatives active as kinase inhibitors
|
| 7514460 | Benzazole analogues and uses thereof
|
| 7550300 | Prediction of bare metal stent restenosis
|
| 7553485 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
| 7588937 | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
|
| 7592318 | 88kDa tumorigenic growth factor and antagonists
|
| 7593820 | Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof
|
| 7595054 | Fusion antigen used as vaccine
|
| 7598272 | Kinase inhibitors
|
| 7598364 | Plasmid encoding canine BMP-7
|
| 7601685 | Growth factor modified protein matrices for tissue engineering
|
| 7608264 | Antibodies that bind to pleiotrophin growth factor receptor
|
| 7611870 | Methods for identifying cancer risk
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7588771 | Microorganisms for therapy
|
| 7588767 | Microorganisms for therapy
|
| 7582756 | 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
|
| 7565248 | Computer system for designing oligonucleotides used in biochemical methods
|
| 7566721 | Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
|
| 7569345 | Gene expression markers for breast cancer prognosis
|
| 7572640 | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
|
| 7572924 | Pyrrole substituted 2-indolinone protein kinase inhibitors
|
| 7575918 | Tissue-specific and pathogen-specific ribozymes
|
| 7575922 | Polypeptide and gene encoding the same
|
| 7576090 | Benzazole analogues and uses thereof
|
| 7576109 | 1,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereof
|
| 7582302 | Needle-free administration of FeLV vaccines
|
| 7612181 | Dual variable domain immunoglobulin and uses thereof
|
